Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.780
+0.200 (7.75%)
At close: Apr 25, 2025, 4:00 PM
2.780
0.00 (0.00%)
After-hours: Apr 25, 2025, 4:43 PM EDT

Orchestra BioMed Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
2.642.763.53-0.785.7
Revenue Growth (YoY)
-4.42%-21.88%---
Cost of Revenue
0.20.190.210.20.15
Gross Profit
2.432.573.32-0.985.56
Selling, General & Admin
23.9320.2614.037.9310.83
Research & Development
42.833.8221.9512.8913.48
Operating Expenses
66.7454.0835.9820.8224.31
Operating Income
-64.3-51.51-32.66-21.8-18.75
Interest Expense
-0.3-1.4--0.93-
Interest & Investment Income
3.655.250.05-0.33
Other Non Operating Income (Expenses)
-0.01-0.29-1.350.7-0.18
EBT Excluding Unusual Items
-60.96-47.95-33.96-22.03-18.6
Gain (Loss) on Sale of Investments
-0.07-0.021.03-0.99-2.75
Other Unusual Items
--1.15-0.68--
Pretax Income
-61.02-49.12-33.61-23.01-21.36
Net Income
-61.02-49.12-33.61-23.01-21.36
Net Income to Common
-61.02-49.12-33.61-23.01-21.36
Shares Outstanding (Basic)
37331522
Shares Outstanding (Diluted)
37331522
Shares Change (YoY)
10.82%121.67%609.97%4.86%-
EPS (Basic)
-1.66-1.48-2.24-10.90-10.61
EPS (Diluted)
-1.66-1.48-2.24-10.90-10.61
Free Cash Flow
-50.85-46.21-29.88-19.7-26.72
Free Cash Flow Per Share
-1.38-1.39-1.99-9.33-13.27
Gross Margin
92.27%93.26%94.03%-97.46%
Operating Margin
-2437.49%-1866.16%-924.34%--328.81%
Profit Margin
-2313.27%-1779.71%-951.26%--374.45%
Free Cash Flow Margin
-1927.48%-1674.09%-845.74%--468.56%
EBITDA
-63.99-51.22-32.44-21.62-18.62
D&A For EBITDA
0.310.290.220.180.14
EBIT
-64.3-51.51-32.66-21.8-18.75
Revenue as Reported
2.642.763.53-0.785.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q